MA26599A1 - Nouveaux derives de benzenesulfonyle, leur preparation et leur application en tant que medicament - Google Patents
Nouveaux derives de benzenesulfonyle, leur preparation et leur application en tant que medicamentInfo
- Publication number
- MA26599A1 MA26599A1 MA25434A MA25434A MA26599A1 MA 26599 A1 MA26599 A1 MA 26599A1 MA 25434 A MA25434 A MA 25434A MA 25434 A MA25434 A MA 25434A MA 26599 A1 MA26599 A1 MA 26599A1
- Authority
- MA
- Morocco
- Prior art keywords
- medicaments
- novel
- preparation
- application
- benzenesulfonyl derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/73—Unsubstituted amino or imino radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C317/32—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07C317/34—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring
- C07C317/36—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring with the nitrogen atoms of the amino groups bound to hydrogen atoms or to carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/70—Sulfur atoms
- C07D213/71—Sulfur atoms to which a second hetero atom is attached
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/84—Nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/38—One sulfur atom
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98100690 | 1998-01-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA26599A1 true MA26599A1 (fr) | 2004-12-20 |
Family
ID=8231273
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA25434A MA26599A1 (fr) | 1998-01-16 | 1999-01-15 | Nouveaux derives de benzenesulfonyle, leur preparation et leur application en tant que medicament |
Country Status (34)
Country | Link |
---|---|
US (1) | US5990105A (fr) |
EP (1) | EP0930302B1 (fr) |
JP (1) | JP3249092B2 (fr) |
KR (1) | KR100319250B1 (fr) |
CN (1) | CN1148356C (fr) |
AR (1) | AR014313A1 (fr) |
AT (1) | ATE236136T1 (fr) |
AU (1) | AU757841B2 (fr) |
BR (1) | BR9900065A (fr) |
CA (1) | CA2258454A1 (fr) |
CO (1) | CO5090847A1 (fr) |
CZ (1) | CZ12099A3 (fr) |
DE (1) | DE69906397T2 (fr) |
DK (1) | DK0930302T3 (fr) |
ES (1) | ES2193607T3 (fr) |
HK (1) | HK1022310A1 (fr) |
HR (1) | HRP990011B1 (fr) |
HU (1) | HUP9900120A3 (fr) |
ID (1) | ID23234A (fr) |
IL (1) | IL128027A (fr) |
MA (1) | MA26599A1 (fr) |
MY (1) | MY121778A (fr) |
NO (1) | NO312065B1 (fr) |
NZ (1) | NZ333706A (fr) |
PE (1) | PE20000170A1 (fr) |
PL (1) | PL194735B1 (fr) |
PT (1) | PT930302E (fr) |
RU (1) | RU2201922C2 (fr) |
SG (1) | SG71898A1 (fr) |
SI (1) | SI0930302T1 (fr) |
TR (1) | TR199900090A3 (fr) |
TW (1) | TW553938B (fr) |
YU (1) | YU1199A (fr) |
ZA (1) | ZA99254B (fr) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7030109B2 (en) | 1999-07-19 | 2006-04-18 | Pharmacia & Upjohn Company | 1,2,3,4,5,6-Hexahydroazepino[4,5-b]indoles containing arylsulfones at the 9-position |
MY122278A (en) * | 1999-07-19 | 2006-04-29 | Upjohn Co | 1,2,3,4,5,6-hexahydroazepino[4,5-b]indoles containing arylsulfones at the 9-position |
DE19956791A1 (de) | 1999-11-25 | 2001-05-31 | Merck Patent Gmbh | Neue Sulfonyloxazolamine |
CN1222511C (zh) * | 2000-11-02 | 2005-10-12 | 惠氏公司 | 作为5-羟色胺-6配体的1-芳基-或1-烷基磺酰基-杂环基吲哚 |
US7034029B2 (en) | 2000-11-02 | 2006-04-25 | Wyeth | 1-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands |
NZ530742A (en) | 2001-08-10 | 2007-07-27 | Hoffmann La Roche | Arylsulfonyl derivatives with 5-HT6 receptor affinity |
BR0213208A (pt) * | 2001-10-09 | 2004-08-31 | Upjohn Co | Compostos de tetraidro- e hexaidro-carbazóis de arilsulfonila substituìda, suas composições e usos |
DK1497266T3 (da) * | 2002-03-27 | 2008-10-06 | Glaxo Group Ltd | Quinolinderivater og deres anvendelse som 5HT6-ligander |
US6875771B2 (en) | 2002-07-26 | 2005-04-05 | Bristol-Myers Squibb Company | Pyridopyrimidine derivatives as 5-HT6 antagonists |
WO2004048365A1 (fr) * | 2002-11-21 | 2004-06-10 | Chiron Corporation | Pyrimidines 2,4,6-trisubstitutees utilisees comme inhibiteurs de phosphotidylinositol (pi) 3-kinase et leur utilisation dans le traitement du cancer |
GB0305575D0 (en) | 2003-03-11 | 2003-04-16 | Glaxo Group Ltd | Novel compounds |
GB0419192D0 (en) * | 2004-08-27 | 2004-09-29 | Merck Sharp & Dohme | Therapeutic agents |
SI1831159T1 (sl) * | 2004-12-21 | 2010-04-30 | Hoffmann La Roche | Derivati tetralina in indana ter njune uporabe |
WO2006119390A1 (fr) * | 2005-05-04 | 2006-11-09 | Vertex Pharmaceuticals Incorporated | Pyridines utiles en tant que modulateurs de canaux ioniques |
JO2660B1 (en) | 2006-01-20 | 2012-06-17 | نوفارتيس ايه جي | Pi-3 inhibitors and methods of use |
BR122020011899B1 (pt) | 2006-06-16 | 2021-05-11 | H. Lundbeck A/S | processos para a preparação de 1-[2-(2,4-dimetil-fenilsulfanil)-fenil]-piperazina e para a fabricação do sal de adição de ácido bromídrico correspondente |
CA2667710A1 (fr) * | 2006-11-09 | 2008-05-15 | F. Hoffmann-La Roche Ag | Arylsulfonyl pyrrolidines en tant qu'inhibiteurs de 5-ht6 |
AU2008213808B2 (en) * | 2007-02-06 | 2011-11-10 | Novartis Ag | PI 3-kinase inhibitors and methods of their use |
WO2009053997A1 (fr) * | 2007-10-26 | 2009-04-30 | Suven Life Sciences Limited | Composés d'aminoarylsulfonamide et leur utilisation comme ligands de 5-ht6 |
EP2288345B1 (fr) | 2008-04-18 | 2015-06-10 | University College Dublin National University Of Ireland, Dublin | Produits psycho-pharmaceutiques |
UA100192C2 (en) | 2008-11-11 | 2012-11-26 | УАЙТ ЭлЭлСи | 1-(arylsulfonyl)-4-(piperazin-1-yl)-1h-benzimidazoles as 5-hydroxytryptamine-6 ligands |
RU2443697C1 (ru) | 2010-12-21 | 2012-02-27 | Александр Васильевич Иващенко | Замещенные метил-амины, антагонисты серотониновых 5-ht6 рецепторов, способы получения и применения |
MX342326B (es) | 2011-09-27 | 2016-09-26 | Novartis Ag | 3-pirimidin-4-il-oxazolidin-2-onas como inhibidoras de idh mutante. |
UY34632A (es) | 2012-02-24 | 2013-05-31 | Novartis Ag | Compuestos de oxazolidin- 2- ona y usos de los mismos |
US9296733B2 (en) | 2012-11-12 | 2016-03-29 | Novartis Ag | Oxazolidin-2-one-pyrimidine derivative and use thereof for the treatment of conditions, diseases and disorders dependent upon PI3 kinases |
KR102277165B1 (ko) | 2013-01-18 | 2021-07-14 | 카르디옥실 파마슈티칼스 인코포레이티드 | 향상된 치료 지수를 갖는 니트록실 공여체 |
MX355945B (es) | 2013-03-14 | 2018-05-07 | Novartis Ag | 3-pirimidin-4-il-oxazolidin-2-onas como inhibidoras de idh mutante. |
JP6454346B2 (ja) | 2013-12-20 | 2019-01-16 | サンシャイン・レイク・ファーマ・カンパニー・リミテッドSunshine Lake Pharma Co.,Ltd. | 芳香族複素環式化合物及び医薬におけるその応用 |
GB201514021D0 (en) | 2015-08-07 | 2015-09-23 | Arner Elias Set Jeno | Novel Pyridines and their use in the treatment of cancer |
WO2018146472A1 (fr) | 2017-02-07 | 2018-08-16 | Oblique Therapeutics Ab | Pyridines à substitution hydrocarbylsulfonyle et leur utilisation dans le traitement du cancer |
JP2020507624A (ja) | 2017-02-07 | 2020-03-12 | オブリーク セラピューティクス アーベー | スルフィニルピリジンおよび癌の治療におけるそれらの使用 |
CA3051537A1 (fr) | 2017-02-07 | 2018-08-16 | Oblique Therapeutics Ab | Pyridines a substitution heteroarylsulfonyle et leur utilisation dans le traitement du cancer |
WO2018146471A1 (fr) | 2017-02-07 | 2018-08-16 | Oblique Therapeutics Ab | Pyridines à substitution hétérocyclylsulfonyle et leur utilisation dans le traitement du cancer |
UA128288C2 (uk) | 2018-03-08 | 2024-05-29 | Інсайт Корпорейшн | СПОЛУКИ АМІНОПІРАЗИНДІОЛУ ЯК ІНГІБІТОРИ PI3K-<font face="Symbol">g</font> |
US11046658B2 (en) | 2018-07-02 | 2021-06-29 | Incyte Corporation | Aminopyrazine derivatives as PI3K-γ inhibitors |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS55151560A (en) * | 1979-05-14 | 1980-11-26 | Ishihara Sangyo Kaisha Ltd | Pyridylthioaniline compound |
JPS60185764A (ja) * | 1984-03-05 | 1985-09-21 | Wako Pure Chem Ind Ltd | ピリジン誘導体の新規な製造法 |
US5389291A (en) * | 1990-11-27 | 1995-02-14 | Merck Patent Gesellschaft Mit Beschrankter Haftung | 3,6-disubstituted 2-halopyridines |
GB9214120D0 (en) * | 1991-07-25 | 1992-08-12 | Ici Plc | Therapeutic amides |
JPH06127956A (ja) * | 1992-10-16 | 1994-05-10 | Copal Co Ltd | ガラスレンズの成形装置 |
JP3907721B2 (ja) * | 1995-08-23 | 2007-04-18 | 株式会社クラレ | 2−アラルキルオキシピリジン類の製造法 |
JP3907722B2 (ja) * | 1995-08-23 | 2007-04-18 | 株式会社クラレ | 2−ヒドロキシピリジン類および/または2(1h)−ピリドン類の製造法 |
WO1997036878A1 (fr) * | 1996-03-29 | 1997-10-09 | Ube Industries, Ltd. | Composes de pyrimidine, procede de production de ces composes et bactericides pour l'agriculture et l'horticulture |
JP3814885B2 (ja) * | 1996-09-03 | 2006-08-30 | 宇部興産株式会社 | 2−シアノピリミジン誘導体、その製造法及び農園芸用の殺菌剤 |
JP2002507197A (ja) * | 1997-05-30 | 2002-03-05 | ビーエーエスエフ アクチェンゲゼルシャフト | 置換チオピリジン |
KR100396431B1 (ko) * | 1998-01-26 | 2003-09-02 | 가부시키가이샤 구라레 | 2-술포닐피리딘 유도체 및 2-[((2-피리딜)메틸)티오]-1h-벤즈이 |
-
1999
- 1999-01-08 PT PT99100149T patent/PT930302E/pt unknown
- 1999-01-08 DE DE69906397T patent/DE69906397T2/de not_active Expired - Fee Related
- 1999-01-08 DK DK99100149T patent/DK0930302T3/da active
- 1999-01-08 EP EP99100149A patent/EP0930302B1/fr not_active Expired - Lifetime
- 1999-01-08 SI SI9930252T patent/SI0930302T1/xx unknown
- 1999-01-08 AT AT99100149T patent/ATE236136T1/de not_active IP Right Cessation
- 1999-01-08 ES ES99100149T patent/ES2193607T3/es not_active Expired - Lifetime
- 1999-01-12 PE PE1999000027A patent/PE20000170A1/es not_active Application Discontinuation
- 1999-01-12 NZ NZ333706A patent/NZ333706A/xx unknown
- 1999-01-13 CA CA002258454A patent/CA2258454A1/fr not_active Abandoned
- 1999-01-13 SG SG1999000077A patent/SG71898A1/en unknown
- 1999-01-13 HR HR98100690.1 patent/HRP990011B1/xx not_active IP Right Cessation
- 1999-01-13 TW TW088100465A patent/TW553938B/zh not_active IP Right Cessation
- 1999-01-13 YU YU1199A patent/YU1199A/sh unknown
- 1999-01-13 IL IL12802799A patent/IL128027A/en unknown
- 1999-01-13 KR KR1019990000667A patent/KR100319250B1/ko not_active IP Right Cessation
- 1999-01-14 JP JP00741099A patent/JP3249092B2/ja not_active Expired - Fee Related
- 1999-01-14 BR BR9900065-2A patent/BR9900065A/pt not_active Application Discontinuation
- 1999-01-14 PL PL330841A patent/PL194735B1/pl not_active IP Right Cessation
- 1999-01-14 ZA ZA9900254A patent/ZA99254B/xx unknown
- 1999-01-14 CZ CZ99120A patent/CZ12099A3/cs unknown
- 1999-01-14 MY MYPI99000139A patent/MY121778A/en unknown
- 1999-01-14 CO CO99001735A patent/CO5090847A1/es unknown
- 1999-01-14 TR TR1999/00090A patent/TR199900090A3/tr unknown
- 1999-01-15 HU HU9900120A patent/HUP9900120A3/hu unknown
- 1999-01-15 ID IDP990038D patent/ID23234A/id unknown
- 1999-01-15 AR ARP990100132A patent/AR014313A1/es unknown
- 1999-01-15 CN CNB99100955XA patent/CN1148356C/zh not_active Expired - Fee Related
- 1999-01-15 US US09/232,775 patent/US5990105A/en not_active Expired - Fee Related
- 1999-01-15 MA MA25434A patent/MA26599A1/fr unknown
- 1999-01-15 NO NO19990187A patent/NO312065B1/no unknown
- 1999-01-15 AU AU12110/99A patent/AU757841B2/en not_active Ceased
- 1999-01-15 RU RU99101350/04A patent/RU2201922C2/ru not_active IP Right Cessation
-
2000
- 2000-02-28 HK HK00101191A patent/HK1022310A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA26599A1 (fr) | Nouveaux derives de benzenesulfonyle, leur preparation et leur application en tant que medicament | |
FR2802206B1 (fr) | Derives de 4-aminopiperidine et leur utilisation en tant que medicament | |
FR15C0024I2 (fr) | Indolinones substituees en position 6, leur preparation et leur utilisation en tant que medicaments | |
DE69806831D1 (de) | Dithiolan Derivate, deren Herstellung und deren Heileffekt | |
DE69604653D1 (de) | Taxol derivate, deren herstellung und diese enthaltende pharmazeutischen zusammenstellungen | |
DE69630145D1 (de) | Taxal derivate, deren herstellung und diese enthaltende pharmazeutische zusammenstellungen | |
FR2783246B1 (fr) | Derives d'azetidine, leur preparation et les medicaments les contenant | |
EE200100431A (et) | 16-halogenoepotilooni derivaadid, nende valmistamismeetod ja farmatseutiline kasutamine | |
FR2761066B1 (fr) | Nouveaux derives du 2-(iminomethyl)amino-phenyle, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant | |
FR2764889B1 (fr) | Nouveaux derives du 2-(iminomethyl)amino-phenyle, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant | |
EE04673B1 (et) | Kinoliini derivaadid, nende valmistamine ja kasutamine ravimina ning neid sisaldavad farmatseutilised kompositsioonid | |
EE04151B1 (et) | Atsüülpiperasinüülpürimidiinide derivaadid, nendevalmistamine ja kasutamine ravimitena | |
EE200000168A (et) | Karboksamidotiasoolderivaadid, nende valmistamine ja neid sisaldavad farmatseutilised kompositsioonid | |
EE200100009A (et) | Bensimidasoolid, nende valmistamine ja kasutamineravimitena | |
EE04276B1 (et) | Kinoliini derivaadid, nende valmistamine ja kasutamine ravimina ning neid sisaldavad farmatseutilised kompositsioonid | |
FR2790474B1 (fr) | Derives de pyridopyranoazepines, leur preparation et leur application en therapeutique | |
EE200200235A (et) | Indeno-, nafto- ja bensotsükloheptadihüdrotiasooli derivaadid, nende valmistamine ja kasutamine anorektiliste ravimitena | |
DE69608680D1 (de) | Taxal derivate, deren herstellung und diese enthaltende pharmazeutische zusammenstellungen | |
IS5730A (is) | Setin tíazóló-pýridazín afleiða, lyfjasamsetningar gerðar úr henni | |
EE200200292A (et) | Asendatud norbornüülaminoderivaadid, nende valmistamine ja kasutamine ravimitena või diagnostilisteainetena ning neid sisaldav ravim | |
DE69610085D1 (de) | Taxol derivate,deren herstellung und diese enthaltende pharmazeutische zusammenstellungen | |
BR9911178B1 (pt) | Derivados de 3-(2-oxo-[1,3']bipirrolidinil-3-ilidenometil)-cefems, bem como preparação farmacêutica e uso dos mesmos | |
FR2787447B1 (fr) | Nouveaux derives de melatonine et medicament comprenant de tels derives | |
EE200000336A (et) | Ehhinokandiini derivaadid, nende valmistamismeetod, vaheühendid ja farmatseutilised kompositsioonid | |
EE05401B1 (et) | Imidasolidiini derivaadid, nende valmistamine ja kasutamine p?letikuvastaste toimeainetena ning neid sisaldav ravimpreparaat |